Medpace (MEDP) PT Raised to $638 at Baird

September 29, 2026 7:18 AM

Baird analyst Eric Coldwell raised the price target on Medpace (NASDAQ: MEDP) to $638.00 (from $624.00) while maintaining a Neutral rating.

No results found